GENEGENETIC TECHNOLOGIES LTD

Nasdaq genetype.com


$ 0.92 $ -0.03 (-3.04 %)    

Monday, 15-Jul-2024 15:59:55 EDT
QQQ $ 496.22 $ 0.19 (0.04 %)
DIA $ 409.69 $ 7.30 (1.81 %)
SPY $ 564.93 $ 3.33 (0.59 %)
TLT $ 94.14 $ 1.31 (1.41 %)
GLD $ 228.28 $ 4.46 (1.99 %)
$ 0.892
$ 0.90
$ 0.00 x 0
$ 0.00 x 0
$ 0.84 - $ 0.92
$ 0.75 - $ 23.65
59,512
na
686,344
$ 1.35
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 genetic-technologies-appoints-mark-ziirsen-as-chief-financial-officer

Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tes...

 genetype-announces-the-introduction-of-suite-of-genetic-risk-assessment-tests-to-canada-and-new-zealand

Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tes...

 genetic-technologies-reported-monday-genetype-identifies-795-of-people-tested-in-us-australia-are-at-risk-of-serious-disease

Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tes...

 genetype-stayhealthy-announce-landmark-distribution-agreement-for-multi-risk-test-to-a-broader-audience-in-the-online-pharmacy-channel-across-north-america

Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tes...

 gtg-launches-genetype-a-novel-comprehensive-risk-assessment-test-that-covers-100-of-women-at-risk-of-developing-breast-and-ovarian-cancer

Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tes...